DRESS syndrome: Part I. Clinical perspectives

Journal of the American Academy of Dermatology

Volumn 68, Issue 5, 2013, Pages 693.e1-693.e14

  Husain, Zain ^a   Reddy, Bobby Y ^b   Schwartz, Robert A ^c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

DRESS syndrome; drug allergy; drug induced hypersensitivity syndrome; eosinophilia; erythroderma; phenytoin hypersensitivity; severe drug eruption; toxic epidermal necrolysis

Indexed keywords

ABACAVIR; AMFEBUTAMONE; AMLODIPINE; AMPICILLIN; CAPTOPRIL; CARBAMAZEPINE; CEFOTAXIME; COTRIMOXAZOLE; DAPSONE; ETHAMBUTOL; FLUOXETINE; IMATINIB; ISONIAZID; LAMOTRIGINE; LINEZOLID; METRONIDAZOLE; MINOCYCLINE; NEVIRAPINE; PHENOBARBITAL; PHENYTOIN; PYRAZINAMIDE; QUININE; RIFAMPICIN; SALAZOSULFAPYRIDINE; STREPTOMYCIN; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN; ZALCITABINE; ZONISAMIDE;

DISEASE DURATION; DRESS SYNDROME; ENZYME DEFECT; EOSINOPHILIA; HEPATITIS; HUMAN; HUMAN HERPESVIRUS 6; LIVER NECROSIS; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS REACTIVATION;

EID: 84876383583     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.01.033     Document Type: Review

References (116)

1. B.D. Newell, M. Moinfar, A.J. Mancini, and A.J. Nopper Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS) Pediatr Dermatol 26 2009 536 546
2. O. Bessmertny, R.C. Hatton, and R.P. Gonzalez-Peralta Antiepileptic hypersensitivity syndrome in children Ann Pharmacother 35 2001 533 538
3. B.H. Chaiken, B.I. Goldberg, and J.P. Segal Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis N Engl J Med 242 1950 897 898
4. S.L. Saltzstein, and L.V. Ackerman Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas Cancer 12 1959 164 182
5. H. Bocquet, M. Bagot, and J.C. Roujeau Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS) Semin Cutan Med Surg 15 1996 250 257
6. R. Wolf, B. Davidovici, H. Matz, K. Mahlab, E. Orion, and Z.M. Sthoeger Drug rash with eosinophilia and systemic symptoms versus Stevens-Johnson syndrome - a case that indicates a stumbling block in the current classification Int Arch Allergy Immunol 141 2006 308 310
7. S.G. Kosseifi, B. Guha, D.N. Nassour, D.S. Chi, and G. Krishnaswamy The dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations J Occup Med Toxicol 1 2006 9
8. N. Norgard, and G.C. Wall Possible drug rash with eosinophilia and systemic symptoms syndrome after exposure to epoetin alfa Am J Health Syst Pharm 62 2005 2524 2526
9. C. Bachmeyer, H. Assier, J.C. Roujeau, and L. Blum Probable drug rash with eosinophilia and systemic symptoms syndrome related to tetrazepam J Eur Acad Dermatol Venereol 22 2008 887 889
10. J.M. White, C.H. Smith, A. Robson, G. Ash, and J.N. Barker DRESS syndrome caused by efalizumab Clin Exp Dermatol 33 2008 50 52
11. A. Volpe, A. Marchetta, P. Caramaschi, D. Biasi, L.M. Bambara, and G. Arcaro Hydroxychloroquine-induced DRESS syndrome Clin Rheumatol 27 2008 537 539
12. A. Caruso, R. Vecchio, F. Patti, and S. Neri Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis Clin Ther 31 2009 580 584
13. J.F. Augusto, J. Sayegh, A. Simon, A. Croue, J.M. Chennebault, and M. Cousin A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis Nephrol Dial Transplant 24 2009 2940 2942
14. E.V. Smith, and D.R. Shipley Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction Age Ageing 39 2010 401 403
15. L. Vauthey, I. Uçkay, S. Abrassart, L. Bernard, M. Assal, and T. Ferry Vancomycin-induced DRESS syndrome in a female patient Pharmacology 82 2008 138 141
16. S. Savard, S. Desmeules, J. Riopel, and M. Agharazii Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome Am J Kidney Dis 54 2009 e17 e20
17. N. Lefebvre, E. Forestier, D. Farhi, M.Z. Mahsa, V. Remy, and O. Lesens Minocycline-induced hypersensitivity syndrome presenting with meningitis and brain edema: a case report J Med Case Rep 1 2007 22
18. K.K. Shaughnessy, S.M. Bouchard, M.R. Mohr, J.M. Herre, and K.S. Salkey Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis J Am Acad Dermatol 62 2010 315 318
19. J.H. Lee, H.K. Park, J. Heo, T.O. Kim, G.H. Kim, and D.H. Kang Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs J Korean Med Sci 23 2008 521 525
20. T. Fujiwaki, T. Yoshikawa, R. Urashima, and C. Ishioka Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin Pediatr Int 50 2008 406 408
21. R. Shalom, S. Rimbroth, D. Rozenman, and A. Markel Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment Ren Fail 30 2008 327 329
22. A. Baruzzi, M. Contin, G. Barbara, C. Cremon, R. De Giorgio, and A. Patrizi Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone Clin Neuropharmacol 26 2003 177 178
23. S.M. Bagshaw, B. Cload, J. Gilmour, S.T. Leung, and T.J. Bowen Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration Ann Allergy Asthma Immunol 90 2003 572 575
24. P.D. Ghislain, A.D. Bodarwe, O. Vanderdonckt, D. Tennstedt, L. Marot, and J.M. Lachapelle Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome Acta Derm Venereol 84 2004 65 68
25. T. Passeron, M.C. Ndir, C. Aubron, and P. Hovette Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin Acta Derm Venereol 84 2004 92 93
26. J.C. Roujeau Clinical heterogeneity of drug hypersensitivity Toxicol 209 2005 123 129
27. C.C. Chiou, L.C. Yang, S.I. Hung, Y.C. Chang, T.T. Kuo, and H.C. Ho Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan J Eur Acad Dermatol Venereol 22 2008 1044 1049
28. S. Tas, and T. Simonart Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) Acta Clin Belg 54 1999 197 200
29. M. MacNeil, D.A. Haase, R. Tremaine, and T.J. Marrie Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline J Am Acad Dermatol 36 1997 347 350
30. S. Tas, and T. Simonart Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update Dermatology 206 2003 353 356
31. Y.J. Jeung, J.Y. Lee, M.J. Oh, D.C. Choi, and B.J. Lee Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome Allergy Asthma Immunol Res 2 2010 123 126
32. M. Mockenhaupt Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy J Dtsch Dermatol Ges 7 2009 142 160
33. M. Ben m'rad, S. Leclerc-Mercier, P. Blanche, N. Franck, F. Rozenberg, and Y. Fulla Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients Medicine (Baltimore) 88 2009 131 140
34. S.R. Knowles, L.E. Shapiro, and N.H. Shear Anticonvulsant hypersensitivity syndrome: incidence, prevention and management Drug Saf 21 1999 489 501
35. C.C. Vittorio, and J.J. Muglia Anticonvulsant hypersensitivity syndrome Arch Intern Med 155 1995 2285 2290
36. S.R. Knowles, L. Shapiro, and N.H. Shear Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature Arch Dermatol 132 1996 934 939
37. E. Begon, and J.C. Roujeau Drug hypersensitivity syndrome: DRESS (drug reaction with eosinophilia and systemic symptoms) [in French] Ann Dermatol Venereol 131 2004 293 297
38. D.J. Naisbitt, S.F. Gordon, M. Pirmohamed, C. Burkhart, A.E. Cribb, and W.J. Pichler Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo Br J Pharmacol 133 2001 295 305
39. H. Peyrière, O. Dereure, H. Breton, P. Demoly, M. Cociglio, and J.P. Blayac Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 155 2006 422 428
40. S. Mallal, E. Phillips, G. Carosi, J.M. Molina, C. Workman, and J. Tomazic HLA-B*5701 screening for hypersensitivity to abacavir N Engl J Med 358 2008 568 579
41. S.R. Knowles, J. Uetrecht, and N.H. Shear Idiosyncratic drug reactions: the reactive metabolite syndromes Lancet 356 2000 1587 1591
42. J. Farrell, D.J. Naisbitt, N.S. Drummond, J.P. Depta, F.J. Vilar, and M. Pirmohamed Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans J Pharmacol Exp Ther 306 2003 229 237
43. D.J. Naisbitt, M. Britschgi, G. Wong, J. Farrell, J.P. Depta, and D.W. Chadwick Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones Mol Pharmacol 63 2003 732 741
44. Y. Fujita, M. Hasegawa, K. Nabeshima, M. Tomita, K. Murakami, and S. Nakai Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome Intern Med 49 2010 409 413
45. J.L. D'Orazio Oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) Clin Toxicol (Phila) 46 2008 1093 1094
46. M. Ganeva, T. Gancheva, R. Lazarova, J. Troeva, I. Baldaranov, and I. Vassilev Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review Int J Dermatol 47 2008 853 860
47. C.W. Kim, G.S. Choi, C.H. Yun, and D.I. Kim Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome J Korean Med Sci 21 2006 768 772
48. W.K. Syn, D.J. Naisbitt, A.P. Holt, M. Pirmohamed, and D.J. Mutimer Carbamazepine-induced acute liver failure as part of the DRESS syndrome Int J Clin Pract 59 2005 988 991
49. K. Hirahara, Y. Kano, Y. Mitsuyama, R. Takahashi, M. Kimishima, and T. Shiohara Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions Clin Exp Dermatol 35 2010 863 868
50. P.D. Ghislain, and J.C. Roujeau Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome Dermatol Online J 8 2002 5
51. J. Natkunarajah, K. Watson, S. Diaz-Cano, G. Mufti, A. du Vivier, and D. Creamer Drug rash with eosinophilia and systemic symptoms and graft-versus-host disease developing sequentially in a patient Clin Exp Dermatol 34 2009 199 201
52. F. Santiago, M. Goncalo, R. Vieira, S. Coelho, and A. Figueiredo Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS) Contact Derm 62 2010 47 53
53. V. Descamps, A. Valance, C. Edlinger, A.M. Fillet, M. Grossin, and B. Lebrun-Vignes Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms Arch Dermatol 137 2001 301 304
54. E. Piñana, S.H. Lei, R. Merino, M. Melgosa, R. De La Vega, and E. Gonzales-Obeso DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy J Clin Pharm Ther 35 2010 365 370
55. N.H. Shear, and S.P. Spielberg Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk J Clin Invest 82 1988 1826 1832
56. F. Fiszenson-Albala, V. Auzerie, E. Mahe, R. Farinotti, C. Durand-Stocco, and B. Crickx A 6-month prospective survey of cutaneous drug reactions in a hospital setting Br J Dermatol 149 2003 1018 1022
57. K.H. Bohan, T.F. Mansuri, and N.M. Wilson Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care Pharmacotherapy 27 2007 1425 1439
58. T. Shiohara, and Y. Kano A complex interaction between drug allergy and viral infection Clin Rev Allergy Immunol 33 2007 124 133
59. P. Cacoub, P. Musette, V. Descamps, O. Meyer, C. Speirs, and L. Finzi The DRESS syndrome: a literature review Am J Med 124 2011 588 597
60. J.R. Sullivan, and N.H. Shear The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 137 2001 357 364
61. J. Ruble, and F. Matsuo Anticonvulsant-induced cutaneous reactions, incidence, mechanisms and management CNS Drugs 12 1999 215 236
62. J. Jurado-Palomo, R. Cabañas, N. Prior, I.D. Bobolea, A.M. Fiandor-Román, and M.C. López-Serrano Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports J Invest Allergol Clin Immunol 20 2010 433 436
63. D.J. Naisbitt, J. Farrell, G. Wong, J.P. Depta, C.C. Dodd, and J.E. Hopkins Characterization of drug-specific T cells in lamotrigine hypersensitivity J Allergy Clin Immunol 111 2003 1393 1403
64. T. Shiohara, M. Inaoka, and Y. Kano Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses Allergol Int 55 2006 1 8
65. D. Picard, B. Janela, V. Descamps, M. D'Incan, P. Courville, and S. Jacquot Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response Sci Transl Med 2 2010 46ra62
66. T. Oskay, A. Karademir, and O.I. Ertürk Association of anticonvulsant hypersensitivity syndrome with herpesvirus 6, 7 Epilepsy Res 70 2006 27 40
67. M. Seishima, S. Yamanaka, T. Fujisawa, M. Tohyama, and K. Hashimoto Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome Br J Dermatol 155 2006 344 349
68. Y. Kano, K. Hiraharas, K. Sakuma, and T. Shiohara Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease Br J Dermatol 155 2006 301 306
69. Y. Wu, J.P. Sanderson, J. Farrell, N.S. Drummond, A. Hanson, and E. Bowkett Activation of T cells by carbamazepine and carbamazepine metabolites J Allergy Clin Immunol 118 2006 233 241
70. G.C. Katsafanas, E.C. Schirmer, L.S. Wyatt, and N. Frenkel In vitro activation of human herpesviruses 6 and 7 from latency Proc Natl Acad Sci U S A 93 1996 9788 9792
71. Y. Kano, M. Inaoka, and T. Shiohara Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia Arch Dermatol 140 2004 183 188
72. I. Gentile, M. Talamo, and G. Borgia Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review BMC Infect Dis 10 2010 49
73. M.A. Gennis, R. Vemuri, E.A. Burns, J.V. Hill, M.A. Miller, and S.P. Spielberg Familial occurrence of hypersensitivity to phenytoin Am J Med 91 1991 631 634
74. H. Watanabe, M. Daibata, M. Tohyama, J. Batchelor, K. Hashimoto, and M. Iijima Chromosomal integration of human herpesvirus 6 DNA in anticonvulsant hypersensitivity syndrome Br J Dermatol 158 2008 640 642
75. Y. Aihara, S.I. Ito, Y. Kobayashi, Y. Yamakawa, M. Aihara, and S. Yokota Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction Br J Dermatol 149 2003 165 169
76. S.I. Hung, W.H. Chung, S.H. Jee, W.C. Chen, Y.T. Chang, and W.R. Lee Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet Genomics 16 2006 297 306
77. A. Alfirevic, A.L. Jorgensen, P.R. Williamson, D.W. Chadwick, B.K. Park, and M. Pirmohamed HLA-B locus in Caucasian patients with carbamazepine hypersensitivity Pharmacogenomics 7 2006 813 818
78. T. Yoshikawa, A. Fujita, A. Yagami, K. Suzuki, K. Matsunaga, and M. Ihira Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome J Clin Virol 37 suppl 1 2006 S92 S96
79. M. Tohyama, and K. Hashimoto New aspects of drug-induced hypersensitivity syndrome J Dermatol 38 2011 222 228
80. R. Takahashi, Y. Kano, Y. Yamazaki, M. Kimishima, Y. Mizukawa, and T. Shiohara Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome J Immunol 182 2009 8071 8079
81. K. Sugita, M. Tohyama, H. Watanabe, A. Otsuka, S. Nakajima, and M. Iijima Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome J Allergy Clin Immunol 126 2010 408 410
82. F.P. Siegal, N. Kadowaki, M. Shodell, P.A. Fitzgerald-Bocarsly, K. Shah, and S. Ho The nature of the principal type 1 interferon-producing cells in human blood Science 284 1999 1835 1837
83. M. Colonna, G. Trinchieri, and Y.J. Liu Plasmacytoid dendritic cells in immunity Nat Immunol 5 2004 1219 1226
84. P. Demoly, M. Viola, E.R. Gomes, and A. Romano Epidemiology and causes of drug hypersensitivity 2007 Karger Basel, Switzerland
85. M. Aihara Pharmacogenetics of cutaneous adverse drug reactions J Dermatol 38 2011 246 254
86. P. Wolkenstein, D. Charue, P. Laurent, J. Revuz, J.C. Roujeau, and M. Bagot Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants Arch Dermatol 131 1995 544 551
87. N.H. Shear, S.P. Spielberg, D.M. Grant, B.K. Tang, and W. Kalow Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity Ann Intern Med 105 1986 179 184
88. B.H. Lauterburg, and M.E. Velez Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity Gut 29 1988 1153 1157
89. G. Choquet-Kastylevsky, L. Intrator, C. Chenal, H. Bocquet, J. Revuz, and J.C. Roujeau Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome Br J Dermatol 139 1998 1026 1032
90. H. Tsutsui, Y. Terano, C. Sakagami, I. Hasegawa, Y. Mizoguchi, and S. Morisawa Drug-specific T cells derived from patients with drug-induced allergic hepatitis J Immunol 149 1992 706 716
91. M. Hertl, and H.F. Merk Lymphocyte activation in cutaneous drug reactions J Invest Dermatol 105 1 suppl 1995 95S 98S
92. M. Mennicke, A. Zawodniak, M. Keller, L. Wilkens, N. Yawalkar, and F. Stickel Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation Am J Transplant 9 2009 2197 2202
93. P.R. Criado, R.F. Criado, M. Avancini Jde, and C.G. Santi Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts An Bras Dermatol 87 2012 435 449
94. N. Bachot, and J.C. Roujeau Physiopathology and treatment of severe drug eruptions Curr Opin Allergy Clin Immunol 1 2001 293 298
95. N. Yawalkar, M. Shrikhande, Y. Hari, H. Nievergelt, L.R. Braathen, and W.J. Pichler Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions J Allergy Clin Immunol 106 2000 1171 1176
96. M. Kashiwagi, M. Aihara, Y. Takahashi, E. Yamazaki, Y. Yamane, and Y. Song Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients J Dermatol 35 2008 683 685
97. M. Pirmohamed, K. Lin, D. Chadwick, and B.K. Park TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients Neurology 56 2001 890 896
98. Y. Suzuki, R. Inagi, T. Aono, K. Yamanishi, and T. Shiohara Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome Arch Dermatol 134 1998 1108 1112
99. M. Tohyama, K. Hashimoto, M. Yasukawa, H. Kimura, T. Horikawa, and K. Nakajima Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome Br J Dermatol 157 2007 934 940
100. Y. Teraki, H. Murota, and S. Izaki Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6 Arch Dermatol 144 2008 232 235
101. S.L. Fernando, C.J. Henderson, and K.S. O'Connor Drug-induced hypersensitivity syndrome with superficial granulomatous dermatitis - a novel finding Am J Dermatopathol 31 2009 611 613
102. Y. Kano, T. Ishida, K. Hirahara, and T. Shiohara Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome Med Clin North Am 94 2010 743 759
103. C.C. Ang, Y.S. Wang, E.L. Yoosuff, and Y.K. Tay Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients J Am Acad Dermatol 63 2010 219 227
104. Y. Kano, and T. Shiohara The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug Immunol Allergy Clin North Am 29 2009 481 501
105. S. Itha, A. Kumar, S. Dhingra, and G. Choudhuri Dapsone induced cholangitis as a part of dapsone syndrome: a case report BMC Gastroenterol 3 2003 21
106. J.C. Roujeau, and R.S. Stern Severe adverse cutaneous reactions to drugs N Engl J Med 331 1994 1272 1285
107. G.P. Bourgeois, J.A. Cafardi, V. Groysman, S.V. Pamboukian, J.K. Kirklin, and A.A. Andea Fulminant myocarditis as a late sequela of DRESS: two cases J Am Acad Dermatol 65 2011 889 890
108. Y. Fujino, M. Nakajima, H. Inoue, T. Kusuhara, and T. Yamada Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome Ann Neurol 51 2002 771 774
109. K. Sakuma, Y. Kano, M. Fukuhara, and T. Shiohara Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome Clin Exp Dermatol 33 2008 287 290
110. M. Arakawa, Y. Kakuto, K. Ichikawa, J. Chiba, N. Tabata, and Y. Sasaki Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia Intern Med 40 2001 331 335
111. S.H. Kardaun, A. Sidoroff, L. Valeyrie-Allanore, S. Halevy, B.B. Davidovici, and M. Mockenhaupt Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156 2007 609 611
112. Y. Seino, M. Yamauchi, C. Hirai, A. Okumura, K. Kondo, and M. Yamamoto A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome Diabet Med 21 2004 1156 1157
113. C.C. Chiou, W.H. Chung, S.I. Hung, L.C. Yang, and H.S. Hong Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection J Am Acad Dermatol 54 2 suppl 2006 S14 S17
114. L.M. Sommers, and R.B. Schoene Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus Arch Intern Med 162 2002 1190 1192
115. N. Bachot, and J.C. Roujeau Differential diagnosis of severe cutaneous drug eruptions Am J Clin Dermatol 4 2003 561 572
116. T. Shiohara, M. Iijima, Z. Ikezawa, and K. Hashimoto The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations Br J Dermatol 156 2007 1083 1084